Business Wire6 小时
Aurion Biotech Appoints Donald Munoz as Chief Financial Officer
Aurion Biotech, Inc. (Aurion), whose mission is to restore vision to millions of patients with life-changing regenerative ...
Personalized Cell Therapy Market: Growing at a CAGR of 25% From 2024-2032 | Pfizer, CARsgen ...
Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...